DDi winner of ‘CorporateLiveWire Innovation & Excellence Awards 2017’ for Global Excellence in Life Science Technology
DDi is constantly upgrading out of conventional processes by developing innovative solutions that facilitate real-time decision making, risk based monitoring, oversight/ governance, central statistical monitoring, and key analytics.
Makro Group, the parent company of DDi, has over two decades of experience in running a life sciences consultancy. Although DDi began seven years ago, it carries with it the legacy and maturity of this experience. DDi has its headquarters in New Jersey but has since spread its operations to USA, UK, Germany, Singapore and India. As such it is well positioned to meet the demands of an expanding product portfolio and the needs of worldwide clients, as well as understanding the demands of an increasingly competitive market. DDi has created a portfolio of products in the fields of clinical development and regulatory/ compliance. By focusing on “smart” features, DDi is able to offer cost-effective and robust IT products to global companies.
Innovation is the key to any industry, particularly where the patient is at the centre of the work. DDi is constantly upgrading out of conventional processes by developing innovative solutions that facilitate real-time decision making, risk based monitoring, oversight/governance, central statistical monitoring, and key analytics.
Our panel of expert judges were impressed with DDi’s sole focus on development, with a series of strategies aiming to expand the current products into other territories and applying their analytics solution effectively also on the commercial side. They demonstrate excellence by thinking innovatively and utilising functional domain well, as well as significantly lowering data costs per patient.
DDi’s technology deals with massive data collected from multiple systems, posing the great challenge of maintaining data integrity and correctness. With a series of policies, processes, standards and tools in place, DDi is able to successfully manage their critical data. A move towards standardizing the data and incorporating checks and balances sees that incorrect data is prevented from entering their system and so DDi is able to offer insightful reports in a meaningful way, with correct metadata and mapping that ensures the data flow from source to destination is seamless and presented with utmost accuracy. Indeed, companies need the best IT systems and tools to manage their research and development, and DDi focuses on this highly specialised area, offering e-clinical products and solutions that enable clinical research and trial designs to work with high computing power and analysis.